Resignation of Dave Tapolczay

Cambridge, UK - 5th February 2020

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs announces the resignation of Dave Tapolczay as non-executive Chairman of the Nuformix Board of Directors with immediate effect.

Download News

Back to all News